中国多发性骨髓瘤诊治指南(2020 年修订)

中华医学会

多发性骨髓瘤(MM)是一种克隆浆细胞异常增殖的恶性疾病，在很多国家是血液系统第 2 位常见恶性肿瘤，多发于老年，目前仍无法治愈。随着新药不断问世及检测手段的提高，MM 的诊断和治疗得以不断改进和完

中文标题：

发布机构：

发布日期：

简要介绍：

多发性骨髓瘤(MM)是一种克隆浆细胞异常增殖的恶性疾病，在很多国家是血液系统第 2 位常见恶性肿瘤，多发于老年，目前仍无法治愈。随着新药不断问世及检测手段的提高，MM 的诊断和治疗得以不断改进和完善。本次指南修订中增加了达雷妥尤单抗联合治疗部分及相关注意事项，在难治复发性 MM 部分增加了嵌合抗原受体 T 细胞免疫疗法，强调自体造血干细胞移植对于适合移植患者仍然具有不可替代的地位。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=036f01c0020891bf, title=中国多发性骨髓瘤诊治指南(2020 年修订), enTitle=, guiderFrom=中华医学会, authorId=0, author=, summary=多发性骨髓瘤(MM)是一种克隆浆细胞异常增殖的恶性疾病，在很多国家是血液系统第 2 位常见恶性肿瘤，多发于老年，目前仍无法治愈。随着新药不断问世及检测手段的提高，MM 的诊断和治疗得以不断改进和完, cover=, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=null, originalUrl=, linkOutUrl=, content=<div class="page" title="Page 1"> <div class="layoutArea"> <div class="column"> <p>多发性骨髓瘤(MM)是一种克隆浆细胞异常增殖的恶性疾病，在很多国家是血液系统第 2 位常见恶性肿瘤，多发于老年，目前仍无法治愈。随着新药不断问世及检测手段的提高，MM 的诊断和治疗得以不断改进和完善。本次指南修订中增加了达雷妥尤单抗联合治疗部分及相关注意事项，在难治复发性 MM 部分增加了嵌合抗原受体 T 细胞免疫疗法，强调自体造血干细胞移植对于适合移植患者仍然具有不可替代的地位。</p> </div> </div> </div>, tagList=[TagDto(tagId=321, tagName=多发性骨髓瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9232, appHits=1815, showAppHits=0, pcHits=2336, showPcHits=7417, likes=7, shares=175, comments=59, approvalStatus=1, publishedTime=Mon Apr 26 12:04:00 CST 2021, publishedTimeString=null, pcVisible=1, appVisible=1, editorId=5433779, editor=Oranhyg是正经人, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=Oranhyg是正经人, createdTime=Mon Apr 26 12:03:54 CST 2021, updatedBy=5433779, updatedName=Oranhyg是正经人, updatedTime=Fri Jan 05 09:15:24 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中国多发性骨髓瘤诊治指南(2020 年修订).pdf)])

中国多发性骨髓瘤诊治指南(2020 年修订).pdf

下载请点击：

评论区 (50)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=2188650, encodeId=dcd82188650fa, content=感谢 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8f64849979, createdName=1574444f2fm, createdTime=Thu Feb 22 10:16:03 CST 2024, time=2024-02-22, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1215612, encodeId=039a12156126b, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220313/1fccd8869aca4c2bbabb274c6aada833/8cdb5c5762b54b208703fcac43dcca47.jpg, createdBy=872f5678021, createdName=jing0309, createdTime=Fri Apr 29 15:44:53 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203631, encodeId=397a120363112, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6e35214130, createdName=147673c8m19暂无昵称, createdTime=Thu Mar 17 22:45:44 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198278, encodeId=992c11982e854, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89455390101, createdName=ms6000000405968600, createdTime=Tue Mar 01 09:47:48 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192394, encodeId=397a11923943a, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48795528355, createdName=小音音, createdTime=Fri Feb 11 17:36:57 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
2024-02-22 1574444f2fm 来自河南省

感谢

14 0
[GetPortalCommentsPageByObjectIdResponse(id=2188650, encodeId=dcd82188650fa, content=感谢 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8f64849979, createdName=1574444f2fm, createdTime=Thu Feb 22 10:16:03 CST 2024, time=2024-02-22, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1215612, encodeId=039a12156126b, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220313/1fccd8869aca4c2bbabb274c6aada833/8cdb5c5762b54b208703fcac43dcca47.jpg, createdBy=872f5678021, createdName=jing0309, createdTime=Fri Apr 29 15:44:53 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203631, encodeId=397a120363112, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6e35214130, createdName=147673c8m19暂无昵称, createdTime=Thu Mar 17 22:45:44 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198278, encodeId=992c11982e854, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89455390101, createdName=ms6000000405968600, createdTime=Tue Mar 01 09:47:48 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192394, encodeId=397a11923943a, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48795528355, createdName=小音音, createdTime=Fri Feb 11 17:36:57 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
2022-04-29 jing0309

感谢分享

34 0
[GetPortalCommentsPageByObjectIdResponse(id=2188650, encodeId=dcd82188650fa, content=感谢 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8f64849979, createdName=1574444f2fm, createdTime=Thu Feb 22 10:16:03 CST 2024, time=2024-02-22, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1215612, encodeId=039a12156126b, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220313/1fccd8869aca4c2bbabb274c6aada833/8cdb5c5762b54b208703fcac43dcca47.jpg, createdBy=872f5678021, createdName=jing0309, createdTime=Fri Apr 29 15:44:53 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203631, encodeId=397a120363112, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6e35214130, createdName=147673c8m19暂无昵称, createdTime=Thu Mar 17 22:45:44 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198278, encodeId=992c11982e854, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89455390101, createdName=ms6000000405968600, createdTime=Tue Mar 01 09:47:48 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192394, encodeId=397a11923943a, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48795528355, createdName=小音音, createdTime=Fri Feb 11 17:36:57 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
2022-03-17 147673c8m19暂无昵称

学习

39 0
[GetPortalCommentsPageByObjectIdResponse(id=2188650, encodeId=dcd82188650fa, content=感谢 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8f64849979, createdName=1574444f2fm, createdTime=Thu Feb 22 10:16:03 CST 2024, time=2024-02-22, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1215612, encodeId=039a12156126b, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220313/1fccd8869aca4c2bbabb274c6aada833/8cdb5c5762b54b208703fcac43dcca47.jpg, createdBy=872f5678021, createdName=jing0309, createdTime=Fri Apr 29 15:44:53 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203631, encodeId=397a120363112, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6e35214130, createdName=147673c8m19暂无昵称, createdTime=Thu Mar 17 22:45:44 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198278, encodeId=992c11982e854, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89455390101, createdName=ms6000000405968600, createdTime=Tue Mar 01 09:47:48 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192394, encodeId=397a11923943a, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48795528355, createdName=小音音, createdTime=Fri Feb 11 17:36:57 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
2022-03-01 ms6000000405968600

学习

39 0
[GetPortalCommentsPageByObjectIdResponse(id=2188650, encodeId=dcd82188650fa, content=感谢 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8f64849979, createdName=1574444f2fm, createdTime=Thu Feb 22 10:16:03 CST 2024, time=2024-02-22, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1215612, encodeId=039a12156126b, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220313/1fccd8869aca4c2bbabb274c6aada833/8cdb5c5762b54b208703fcac43dcca47.jpg, createdBy=872f5678021, createdName=jing0309, createdTime=Fri Apr 29 15:44:53 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203631, encodeId=397a120363112, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6e35214130, createdName=147673c8m19暂无昵称, createdTime=Thu Mar 17 22:45:44 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198278, encodeId=992c11982e854, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89455390101, createdName=ms6000000405968600, createdTime=Tue Mar 01 09:47:48 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192394, encodeId=397a11923943a, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48795528355, createdName=小音音, createdTime=Fri Feb 11 17:36:57 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
2022-02-11 小音音

学习#学习#

37 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肿瘤科指南

中国多发性骨髓瘤诊治指南(2020 年修订)

相关指南

科室

工具

服务